top of page
HOME
ABOUT US
SOCIAL IMPACT
STRATEGY
GENE THERAPY
CELL THERAPY
RNA-BASED THERAPY
TARGETED THERAPIES
MICROBIOME
TEAM
PORTFOLIO
VENTURE PORTFOLIO
PAST PORTFOLIO
4BATLE ICAV
NEWSROOM
CONTACT
More
Use tab to navigate through the menu items.
NEWSROOM
Posts Coming Soon
Explore other categories in this blog or check back later.
ARCHIVE
December 2022
November 2022
October 2022
September 2022
June 2022
April 2022
March 2022
February 2022
January 2022
December 2021
October 2021
April 2021
March 2021
January 2021
December 2020
November 2020
October 2020
July 2020
June 2020
May 2020
SEARCH BY TAGS
portfolio
4BIO Ventures II
investment
Orchard Therapeutics
appointment
SparingVision
approval
collaboration
acquisition
advisory board
CodeBio
Spark Therapeutics
Takeda
AAV
ADC Therapeutics
Carisma
IPO
publication
Ray Therapeutics
Redpin Therapeutics
review
TiGenix
4BATLE
AI
Araris
awards
BLA
clinical trials
EGLS
Entact
ETF
exit
grant
Harbor Capital
IND
Insig AI
Intellia
Kyowa Kirin
Luca Science
merger
Moderna
pricing
results
venture
FOLLOW US
bottom of page
